351 related articles for article (PubMed ID: 33257382)
21. [A case of malignant peritoneal mesothelioma diagnosed with laparoscopic biopsy].
Yagi Y; Maeda T; Yoshimitsu Y; Sakuma H
Gan To Kagaku Ryoho; 2014 Aug; 41(8):995-7. PubMed ID: 25132032
[TBL] [Abstract][Full Text] [Related]
22. Malignant Peritoneal Mesothelioma: Treatment Options and Survival.
Salo SAS; Ilonen I; Laaksonen S; Myllärniemi M; Salo JA; Rantanen T
Anticancer Res; 2019 Feb; 39(2):839-845. PubMed ID: 30711965
[TBL] [Abstract][Full Text] [Related]
23. A Complete Response to Pembrolizumab in Malignant Peritoneal Mesothelioma: A Case Report.
Bairos Menezes M; Pedroso de Lima R; Dunões I; Inácio M; Dinis R
Cureus; 2024 Jan; 16(1):e52716. PubMed ID: 38384604
[TBL] [Abstract][Full Text] [Related]
24. The role of imaging in diagnosis and management of malignant peritoneal mesothelioma: a systematic review.
Carlson B; Harmath C; Turaga K; Kindler HL; Armato SG; Straus C
Abdom Radiol (NY); 2022 May; 47(5):1725-1740. PubMed ID: 35257201
[TBL] [Abstract][Full Text] [Related]
25. Malignant peritoneal mesothelioma: contribution and limitation of imaging for its diagnosis.
Marrannes J; Delvaux S; Verheezen J
JBR-BTR; 2009; 92(5):248-50. PubMed ID: 19999328
[TBL] [Abstract][Full Text] [Related]
26. A Phase II Trial of Nivolumab With Chemotherapy Followed by Maintenance Nivolumab in Patients With Pleural Mesothelioma After Surgery: The NICITA Study Protocol.
Shah R; Klotz LV; Chung I; Feißt M; Schneider MA; Riedel J; Bischoff H; Eichhorn ME; Thomas M
Clin Lung Cancer; 2021 Mar; 22(2):142-146. PubMed ID: 33158765
[TBL] [Abstract][Full Text] [Related]
27. Intraperitoneal nivolumab in a patient with pancreatic cancer and refractory malignant ascites.
Wang ST; Chiu CF; Bai HJ; Bai LY
Eur J Cancer; 2021 May; 148():48-50. PubMed ID: 33735808
[No Abstract] [Full Text] [Related]
28. Impressive clinical response to anti-PD-1 therapy in epithelioid mesothelioma with high clonal PD-L1 expression and EML4-ALK rearrangement.
Bronte G; Delmonte A; Burgio MA; Verlicchi A; Puccetti M; Bravaccini S; Cravero P; Tumedei MM; Diano D; Rossi G; Ulivi P; Martinelli G; Crinò L
Lung Cancer; 2020 Apr; 142():47-50. PubMed ID: 32088605
[TBL] [Abstract][Full Text] [Related]
29. A case of malignant peritoneal mesothelioma suggesting the utility of combining double-contrast radiography and endoscopy with computed tomography for diagnosis.
Saito H; Hasuda S; Nasu J; Kitaoka M; Matsushita I
Clin J Gastroenterol; 2017 Aug; 10(4):371-376. PubMed ID: 28646342
[TBL] [Abstract][Full Text] [Related]
30. [A case of ascities decrease in malignant peritoneal mesothelioma by weekly intra-peritoneal administration of cisplatin and paclitaxel].
Ami K; Nagahama T; Andou M; Nawa K; Ganno H; Ohbu M; Kimu K; Ito T; Yamauchi A; Ichikawa S; Kobo T; Takaba E
Gan To Kagaku Ryoho; 2005 Oct; 32(11):1709-11. PubMed ID: 16315916
[TBL] [Abstract][Full Text] [Related]
31. Clinical Response of Primary Malignant Pericardial Mesothelioma with Peritoneal Dissemination to Nivolumab.
Fujiwara S; Kano Y; Maejima Y; Fujioka T; Tamura K; Kirimura S; Miyake S; Okamoto R
Intern Med; 2024 Feb; 63(4):513-519. PubMed ID: 37380459
[TBL] [Abstract][Full Text] [Related]
32. Clinical Efficacy of Immune Checkpoint Inhibitors in Patients With Advanced Malignant Peritoneal Mesothelioma.
Raghav K; Liu S; Overman M; Morani A; Willette A; Fournier K; Varadhachary G
JAMA Netw Open; 2021 Aug; 4(8):e2119934. PubMed ID: 34357397
[TBL] [Abstract][Full Text] [Related]
33. Acute popliteal thrombus workup leads to discovery of primary peritoneal mesothelioma in the absence of any known asbestos exposure.
Ahmed ST; Barvo M; Kamath N; Alweis R
BMJ Case Rep; 2020 Feb; 13(2):. PubMed ID: 32041759
[TBL] [Abstract][Full Text] [Related]
34. Mesothelioma in children and adolescents: the European Cooperative Study Group for Pediatric Rare Tumors (EXPeRT) contribution.
Orbach D; André N; Brecht IB; López Almaraz R; Ben-Ami T; Vermersch S; Carton M; Virgone C; Bisogno G; Schneider DT; Bajciova V; Reguerre Y; Galateau-Salle F; Stachowicz-Stencel T; Dvir R; Rees H; Bien E; Ferrari A; Ben Arush M
Eur J Cancer; 2020 Nov; 140():63-70. PubMed ID: 33049597
[TBL] [Abstract][Full Text] [Related]
35. CheckMate 743: A Glimmer of Hope for Malignant Pleural Mesothelioma.
Uprety D
Clin Lung Cancer; 2021 Mar; 22(2):71-73. PubMed ID: 33358660
[No Abstract] [Full Text] [Related]
36. Correlation between immune-related adverse events and therapeutic effects of nivolumab in patients with malignant pleural mesothelioma.
Yoneda H; Nokihara H; Mitsuhashi A; Ozaki R; Yabuki Y; Ogino H; Otsuka K; Nishioka Y
BMC Pulm Med; 2021 Nov; 21(1):373. PubMed ID: 34781910
[TBL] [Abstract][Full Text] [Related]
37. Response to Ipilimumab and Nivolumab in a Patient With Malignant Peritoneal Mesothelioma.
Rizzolo A; Ah-Lan KC; Nu TNT; Alcindor T
Clin Colorectal Cancer; 2022 Dec; 21(4):371-374. PubMed ID: 36055919
[No Abstract] [Full Text] [Related]
38. Epidemiology of malignant peritoneal mesothelioma: A population-based study.
Salo SAS; Ilonen I; Laaksonen S; Myllärniemi M; Salo JA; Rantanen T
Cancer Epidemiol; 2017 Dec; 51():81-86. PubMed ID: 29080447
[TBL] [Abstract][Full Text] [Related]
39. Programmed Death 1 Blockade With Nivolumab in Patients With Recurrent Malignant Pleural Mesothelioma.
Quispel-Janssen J; van der Noort V; de Vries JF; Zimmerman M; Lalezari F; Thunnissen E; Monkhorst K; Schouten R; Schunselaar L; Disselhorst M; Klomp H; Hartemink K; Burgers S; Buikhuisen W; Baas P
J Thorac Oncol; 2018 Oct; 13(10):1569-1576. PubMed ID: 29908324
[TBL] [Abstract][Full Text] [Related]
40. [Malignant peritoneal mesothelioma is a rare disease].
Poulsen A; Pedersen G
Ugeskr Laeger; 2014 Dec; 176(25A):. PubMed ID: 25497620
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
